drugset / Trial / NCT05040698

Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa

NCT05040698

NaSingle-groupOpen-labelTreatment

Summary

A 16 week exploratory, Proof of Concept study to evaluate the effect of Fostamatinib (12 weeks of treatment) upon cutaneous inflammation in Hidradenitis Suppurativa.

Timeline

Start
2021-10-01
Primary completion
2023-01-13
Completion
2023-01-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostamatinib Small molecule 100 mg